You are using an older browser version. Please use a supported version for the best MSN experience.

Packaging error leads to recall of birth-control pills

New York Daily News logo New York Daily News 3/6/2019 STORM GIFFORD
a close up of a coffee cup on a plate © iStock

A contraceptive manufacturer issued a major recall Monday after a packaging error that could affect some of its birth-control pills.

The Apotex Corp. is asking women taking drospirenone and ethinylestradiol birth-control tablets to check the packaging with the ID number 60505-4183-3 imprinted on inner and outer cartons. The packaging could have an improper tablet arrangement or empty slot for a pill, which means the patient might take the wrong medicine or incorrect dosage, reported WebMD.

“As a result of this packaging error, where a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to variation in the dosage consumed,” Apotex said in a statement.

The combination of drospirenone and ethinylestradiol is an estrogen/progestin oral contraceptive. The tablets in the inner carton are arranged as 21 active yellow tablets followed by seven white placebo tablets.

In its recall notice, the company claimed it had received no pregnancy or adverse effects reports. The notice also urges those with these tablets to consult with their health-care provider or pharmacy. They should also continue their therapy or use a nonhormonal method — such as condoms or diaphragms — according to the notice.

Recalled products, which expire in August 2020, can be returned to the pharmacy from where the pills were dispensed.


More from New York Daily News

New York Daily News
New York Daily News
image beaconimage beaconimage beacon